Self-Management in Young Adults With Type 1 Diabetes
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- Case Western Reserve University
- Study ID
- NCT04975230
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 26 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sleep Self-Management — BEHAVIORALIntervention delivered by a sleep coach will include 1) initial in-person 50 min consultation; 2) brief 5 min weekly follow ups in a format TBD; and 3) in-person 30 min booster sessions every 3 weeks (total 13 sessions).
Study Details
Type 1 Diabetes (T1D) affects 1.6 million Americans, and only 14% of young adults age 18-25 years achieve glycemic targets (glycosylated hemoglobin A1C \<7.0%). Achieving glycemic targets is associated with reduced risk for both micro-and macrovascular complications, better neurocognitive function, and better diabetes quality of life. In lab studies, sleep deprivation led to impaired glucose tolerance and insulin sensitivity in adults without chronic condition and in one study of adults with T1D. Extending sleep in natural environments contributes to improved insulin sensitivity and glucose levels, neurocognition, and psychological symptoms in young adults without chronic conditions. Modifiable dimensions of sleep health (appropriate sleep duration, stability, and timing) are associated with better glycemic control in adults with T1D. Therefore, improving sleep duration, stability, and timing may be potential therapeutic targets to improve glucoregulation and clinical outcomes (diabetes self-management, neurocognitive function, and symptoms) in this high-risk population. The overall objective is to test and compare the effects of a cognitive-behavioral sleep self-management intervention (sleep extension and consistency in sleep timing) compared to an attention control condition (habitual sleep duration + diabetes self-management education) on improving sleep duration, stability, and timing, and glycemia (glycemic control and glucose variability) in short-sleeping young adults with T1D in a pilot randomized controlled trial.
Key Dates
- Start date
- Apr 29, 2022
- Status verified
- Jan 2026
- Primary completion
- Oct 31, 2023
- Completion
- Nov 1, 2023
Study Design
- Enrollment
- 39 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Sleep Self-ManagementThe Sleep Self-Management Intervention involves an initial 50-minute face-to-face interactive session in a private location. Participants are asked to extend time in bed by 1 hour and consistently maintain the extension on both weekends and weekdays. Bedtimes and waketimes will be assessed to ascertain which time is most modifiable for the participant's lifestyle and routine. There will be weekly follow-ups and in-person 3-week booster sessions. Sleep reports generated by the actigraphy will be shared with participants with brief action planning and goal setting to address progress towards goal achievement. A need to revise plans for future weeks will be the booster sessions' major goal.
- No Intervention: Diabetes Self-Management EducationThe Attention Control arm will receive Diabetes Self-Management Education at the initial consultation visit via in-person contact at T1. There will be weekly follow-ups and in-person 3-week sessions. A Diabetes Self-Management Tracking Form will be used to monitor the weekly acquisition of information and plans for the 6-week intervention and at the 3-month and 6-month data points.
Primary Outcome Measure
Non-dominant Wrist-worn Actigraph to be Worn 24/7 (Spectrum Plus) [ Time Frame: From (T0) baseline through 12-week intervention period (T2) captured immediately post intervention period. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Hospitals of Cleveland Medical Center | Cleveland | Ohio | 44106-4904 | - |
Find similar trials in Cleveland, OH
Related Studies
- Immune Function and the Progression to T1DRecruiting · University of Florida · Gainesville, Florida
- PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early LifeRecruiting · University of Colorado, Denver · Aurora, Colorado
- Effect of C-peptide on Hypoglycemic CounterregulationEARLY_PHASE1 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- Registry for Stage 2 Type 1 DiabetesRecruiting · Sanofi · Baltimore, Maryland